Abstract
Objective
To determine the proportion of patients of type 2 Diabetes taking oral antidiabetics with self reported hypoglycemia and its causes.
Background
Hypoglycemia, an acute complication of diabetes mellitus is not only responsible for recurrent morbidity but also can lead to permanent brain damage or fatality if not recognized and treated in time. Also, hypoglycemia prevents achieving glycemic targets in diabetic patients.
Methods
Cross-sectional observation study of 70 patients of type 2 diabetes on oral anti-diabetics was conducted at Lok Nayak Hospital to determine the proportion of patients with self reported hypoglycemia and also to find out the various causes of hypoglycemia by subjecting them to a structured questionnaire. Hypoglycemia was considered when patient experienced at least one symptom, at least 2–3 times in last one month and symptom(s) were relieved by consuming sugar/meal.
Results
38.6% of the study subjects had hypoglycemia, out of which 92.59% patients had symptomatic hypoglycemia. Out of the patients experiencing hypoglycemia, 32% had severe episodes, 12% visited the hospital and 48% had more than 5 episodes per month. Dizziness was the commonest reported symptom (64%), followed by palpitations (52%). Attributed causes of hypoglycemia were missing meal (64%), drugs other than oral anti-diabetics (44%), sulfonylureas (44.2% in patients taking vs. 26.9% in patients not taking sulfonylurea), comorbidities (41% with vs. 22.4% without comorbidities) and lower socioeconomic status. One-third of patients experiencing were checking blood glucose levels during the symptoms. Highest prevalence of hypoglycemia was seen with HbA1c < 6.5% (p-value 0.04 when compared with subjects with HbA1c ≥ 6.5%), followed by ≥ 8% and least in 6.5–7.9%.
Conclusions
Lower prevalence of hypoglycemia in our study compared to other similar studies could be because of non-inclusion of patients on insulin in our study. High prevalence of multiple episodes justify the fact that hypoglycemia begets hypoglycemia. Hypoglycemia progressively increased as socioeconomic status changed from higher to lower, possibly due to non-availability of glucometer and lack of information. U-shaped correlation of hypoglycemic events was found with HbA1c levels.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13410-024-01326-4/MediaObjects/13410_2024_1326_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13410-024-01326-4/MediaObjects/13410_2024_1326_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13410-024-01326-4/MediaObjects/13410_2024_1326_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13410-024-01326-4/MediaObjects/13410_2024_1326_Fig4_HTML.png)
Similar content being viewed by others
References
Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709–28.
Mathew P, Thoppil D. Hypoglycemia. [Updated 2022 Jul 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2022. https://www.ncbi.nlm.nih.gov/books/NBK534841. Accessed 1 Aug 2022.
American Diabetes Association. 6 Glycemic targets: Standards of medical care in diabetes- 2022. Diabetes Care. 2022;45(Suppl. 1):S83–96.
Cryer PE. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness. Endocrinol Metab Clin North Am. 1999;28(3):495–500.
Viswanathan M, Joshi SR, Bhansali A. Hypoglycemia in type 2 diabetes: standpoint of an experts’ committee (India hypoglycemia study group). Indian J Endocrinol Metab. 2012;16(6):894–8.
Samya V, Shriraam V, Jasmine A, Akila GV, Anitha Rani M, Durai V, et al. Prevalence of hypoglycemia among patients with type 2 diabetes mellitus in a Rural Health Center in South India. J Prim Care Community Health. 2019;10:1–7.
Shriraam V, Mahadevan S, Anitharani M, Jagadeesh NS, Kurup SB, Vidya TA, et al. Reported hypoglycemia in type 2 diabetes mellitus patients: prevalence and practices-a hospital-based study. Indian J Endocr Metab. 2017;21(1):148–53.
Edridge CL, Dunkley AJ, Bodicoat DH, Rose TC, Gray LJ, Davies MJ, et al. Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies. PLoS One. 2015;10(6): e0126427.
Mitchell BD, Vietri J, Zagar A, Curtis B, Reaney M. Hypoglycaemic events in patients with type 2 diabetes in the United Kingdom: associations with patient-reported outcomes and self-reported HbA1c. BMC Endocr Disord. 2013;13:59.
Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med. 2001;161(13):1653.
Cahn A, Mosenzon O, Bhatt DL, Leibowitz G, Yanuv I, Rozenberg A, et al. Hypoglycaemia manifestations and recurrent events: lessons from the SAVOR-TIMI 53 outcome study. Diabetes Obes Metab. 2017;19(7):1045–50.
Lipska KJ, Warton EM, Huang ES, Moffet HH, Inzucchi SE, Krumholz HM, et al. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the diabetes and aging study. Diabetes Care. 2013;36(11):3535–42.
Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.
ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical clearance
The study was conducted after taking approval from Institutional Ethics Committee of Maulana Azad Medical College dated 14/01/2021 vide letter no. F.1/IEC/MAMC/(82/10/2020/No.64. Each subject was given a consent form to fill. Subjects were explained the purpose of study and his/ her right to quit at any time without giving the reasons. Patient’s information was dealt with confidentiality. Any abnormality detected during the screening of subjects was appropriately managed.
Conflicts of interest
There are no conflicts of interest to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Golani, M., Pandit, S. & Singla, S. Self reported hypoglycemia in patients with type 2 diabetes mellitus taking oral anti-diabetics. Int J Diabetes Dev Ctries (2024). https://doi.org/10.1007/s13410-024-01326-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13410-024-01326-4